Greenwood Capital Associates LLC Clovis Oncology, Inc. Transaction History

Greenwood Capital Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$29.37 - $49.48 $205,031 - $345,419	-6,981 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$42.06 - $62.4 $59,220 - $87,859	1,408 Added 25.26%	6,981 $317,000
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $1,603 - $2,167	-32 Reduced 0.57%	5,573 $294,000
Q4 2017 Feb 02, 2018	BUY	$57.69 - $84.58 $57,459 - $84,241	996 Added 21.61%	5,605 $381,000
Q3 2017 Nov 03, 2017	BUY	$67.17 - $84.81 $309,586 - $390,889	4,609	4,609 $380,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.